Personalized Cancer Medicine
Personalized cancer medicine in India using pathology, clinically relevant biomarkers and molecular testing to guide evidence-based targeted, immune, endocrine or other cancer treatment.
Наши услуги БЕСПЛАТНЫ, и ваш счёт в больнице от этого не увеличивается!
Personalized Cancer Medicine: общие сведения
Personalized cancer medicine in India uses the tumour’s pathology, biomarkers and molecular features together with the patient’s stage, previous treatment, organ function and overall health to guide cancer therapy. It is not a single treatment and does not mean every patient needs broad genomic sequencing. The useful question is whether a specific test result can change an evidence-based treatment decision.
Evaluation usually begins with expert pathology review and confirmation of the cancer type and stage. Depending on the tumour, clinically relevant testing may include immunohistochemistry, FISH, PCR, next-generation sequencing (NGS), homologous-recombination or mismatch-repair testing, liquid biopsy or germline testing when inherited cancer risk is suspected. Sample quality matters: old or small biopsy material may be insufficient, and a new biopsy is sometimes required. A detected mutation is not automatically actionable; variants must be interpreted in the context of approved indications, clinical evidence and previous therapies.
Treatment may include targeted therapy, immunotherapy, endocrine therapy, chemotherapy or a clinical trial when supported by the cancer type and biomarker profile. Molecular results can also show that a proposed drug is unlikely to help. Treatment response and toxicity still require standard oncology monitoring, and repeat profiling may occasionally be useful when cancer progresses or develops resistance.
Cost in India depends on pathology review, the number and type of biomarkers tested, focused versus broad NGS, tissue versus liquid biopsy, genetic counselling when indicated, and the medicine or treatment ultimately selected. Major Indian tertiary cancer centres provide molecular pathology, genomic laboratories, medical oncology and multidisciplinary tumour boards. Medical Help India is a connection platform that can connect international patients with a suitable healthcare partner to review pathology and molecular reports, determine which additional tests are clinically useful and obtain an individual treatment and cost estimate.
Что входит
Почему стоит рассмотреть лечение в Индии?
Доступ к опытным специалистам
Современные методы лечения и диагностики
Более доступная стоимость лечения в больнице
Более короткие сроки ожидания лечения
Помощь в сравнении больниц, планов лечения и стоимости
Помощь с записью, поездкой и последующим наблюдением
Стоимость в Индии
USDИтоговая стоимость зависит от результатов медицинского обследования, больницы, категории палаты и медицинских показаний.
Как это работает
Оставьте свои данные
Расскажите, что вас беспокоит, сколько вам лет и где вы сейчас находитесь.
Мы вам позвоним
Мы звоним вам, чтобы обсудить вашу ситуацию, потребности и вопросы.
Получите план лечения
Получите информацию о наиболее подходящем плане лечения, больнице и ориентировочной стоимости.
Выберите план
Изучите варианты и согласуйте план лечения и поездки.
Получите полную поддержку
Получайте полную поддержку на каждом этапе лечения.
Пройдите лечение в Индии
Пройдите запланированное лечение при поддержке на протяжении всего пребывания.
Personalized Cancer Medicine: ведущие больницы
Все больницы →
Personalized Cancer Medicine: ведущие врачи
Все врачи →
Часто задаваемые вопросы
How much does Personalized Cancer Medicine cost in India?
Cost depends on pathology review, focused biomarker tests versus broad NGS, tissue or liquid-biopsy testing, genetic counselling when indicated and the cancer treatment selected from the results. Molecular testing and ongoing targeted or immune therapy should be itemised separately because drug choice and duration can dominate the total cost.
Which medical reports are useful to have ready for Personalized Cancer Medicine?
Have ready: the pathology report and, if available, pathology slides or block details, the latest staging scans, oncology notes and all existing biomarker, molecular or germline genetic reports. Include previous surgery, radiotherapy and systemic-treatment summaries, current medicines, treatment response or progression information and any family cancer history relevant to hereditary testing.
What does personalized cancer medicine mean?
It uses tumour pathology, biomarkers and patient-specific factors to guide treatment choices.
Does every cancer patient need genomic testing?
No. The usefulness of molecular testing depends on cancer type, stage and whether results are likely to change treatment.
Does finding a mutation always mean there is a targeted drug?
No. Some alterations are not actionable, and treatment decisions must consider clinical evidence and approved options.
Наши услуги бесплатны
Мы связываем вас с ведущими больницами и специалистами Индии. Оплату вы вносите напрямую больнице.